Assuta Medical Center
Tel Aviv, Israel
NCT Number: NCT05134389
One Anastomosis Gastric Bypass (OAGB) surgery is a type of bariatric surgery (BS) which is gaining popularity worldwide and is considered to be a simple, safe and effective bariatric procedure in terms of weight loss and comorbidities resolution. However, only limited data exists on the nutritional and gastrointestinal (GI) consequences of this procedure.
This study aimed to gain information on GI and nutritional parameters from a large sample of OAGB patients living in 3 different countries.
Post-OAGB patients across Israel (n=277), Spain (n=105) and Portugal (n=111) were recruited to the study based on the time elapsed since surgery [1-6 months (1-6M), 6-12 months (6-12M) and 1-5 years (1-5Y) post-surgery]. Participants were asked to complete an anonymous survey delivered by SurveyMonkey®️ software which included data on demographics, comorbidities, anthropometrics, GI outcomes and satisfaction with the procedure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tel Aviv, Israel
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exposure to One Anastomosis Gastric Bypass
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by weight changes
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by satisfaction and quality of life scales (scale of 0-100)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by attendance to follow-up regime (no. of meetings)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by adherence to the bariatric surgery health recommendations [physical activity (min/week), alcohol drinking (doses/day), smoking (current/past/never) and supplementation usage (non/monthly/weekly/daily)]
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by adherence to the bariatric surgery eating recommendations questionnaire (0=no, 1=partial, 2=yes)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by taste change, smell change and food aversion questionnaire (yes/no/open text for additional information)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by self-reported questionnaire for quick assessment of food tolerance after bariatric surgery (scored between 1-27, while higher scores represents better tolerance)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by no. defecations per day and defecations texture
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by severity of dyspepsia symptoms scale (4-point graded scale -0 represents absence of symptoms and 3 represents severe symptoms which interfere to perform normal activities)
Time frame: Only once in accordance to the time group (1-6 months, 6-12 months and 1-5 years post-surgery).
Measured by Gastrointestinal Symptom Rating Scale (GSRS) (scored 15-105, while higher scores represents more severe symptoms)
Assuta Medical Center
Other
Survey on Gastrointestinal and Nutritional Parameters Among One Anastomosis Gastric Bypass Patients From Different Countries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06200961
Body Weight, Digestive System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial Details